Moderate vs light cycling: neurotrophins barely differed

A single bout of aerobic exercise is widely believed to raise circulating neurotrophins such as brain-derived neurotrophic factor, and the authors note strong evidence that one session can alter serum neurotrophin concentrations and drive neural adaptation. For people rehabilitating after a stroke, that raises an obvious practical question: does pushing harder in a session buy a bigger biochemical response, or is gentle movement enough? Intensity is one of the few dials a rehabilitation team can adjust safely and cheaply. This trial set out to test whether low- versus moderate-intensity continuous exercise changes the neurotrophin response in the subacute phase after a first ischaemic stroke.

Thirty patients after a first ischaemic stroke, with a mean age of 65.64 (SD 9.34) years, were randomly assigned to a low-intensity continuous exercise group (n=15) or a moderate-intensity continuous exercise group (n=15). Exercise intensity was established using the Graded Cycling Test with the Talk Test. Serum neurotrophin concentrations were measured by enzyme-linked immunosorbent assay around the single session. The team also characterised participants with the Addenbrooke's Cognitive Examination III for cognition, the Rivermead Motor Assessment for functional ability, and the Beck Depression Inventory for depressive symptoms, and tracked lactate concentrations.

The formal inferential analysis, a two-way repeated-measures ANOVA, found no significant group-by-time interactions for the serum neurotrophins; the one exception was lactate concentration, which behaved differently across intensities as would be expected physiologically. Descriptive, median-based analysis told a softer story: in the moderate-intensity group, serum BDNF rose by a median of 1.9 ng/mL (95% bootstrap CI 0.7 to 2.8) and serum irisin fell by a median of 257.4 ng/mL (95% bootstrap CI -490.1 to -206.8). The authors were explicit that neurotrophin responses looked broadly similar across the two intensities on mean-based testing.

The background literature suggests single aerobic sessions can shift neurotrophins, and this study does not overturn that; what it complicates is the assumption that higher intensity reliably produces a larger response, at least in subacute stroke patients within a small sample. The divergence between descriptive medians and mean-based tests is itself informative, hinting at variable individual responses that a 30-person trial cannot resolve. Open questions include whether repeated sessions over weeks produce intensity-dependent differences, whether any biomarker shift translates into cognitive or motor recovery, and how stroke severity modifies the response.

This is a reason to be cautious about claims that harder aerobic sessions automatically mean a bigger brain-chemistry payoff, particularly in older adults early after a stroke. The clearest intensity-related signal here was lactate, which is a straightforward marker of exercise effort rather than a measure of brain benefit. Any BDNF or irisin movement described came from exploratory descriptive statistics in a very small group, so it should be read as a hint rather than a result. For a general reader, the useful takeaway is that acute biomarker changes are not the same thing as recovery, and single-session studies cannot tell you what months of training would do.